These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1927483)

  • 1. Delayed onset of ototoxic effects of gentamicin in treatment of Menière's disease.
    Magnusson M; Padoan S; Karlberg M; Johansson R
    Acta Otolaryngol Suppl; 1991; 481():610-2. PubMed ID: 1927483
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed onset of ototoxic effects of gentamicin in treatment of Menière's disease. Rationale for extremely low dose therapy.
    Magnusson M; Padoan S
    Acta Otolaryngol; 1991; 111(4):671-6. PubMed ID: 1950529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed onset of ototoxic effects of gentamicin in patients with Meniére's disease.
    Magnusson M; Padoan S; Karlberg M; Johansson R
    Acta Otolaryngol Suppl; 1991; 485():120-2. PubMed ID: 1843163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritative spontaneous nystagmus following intratympanic gentamicin for Menière's disease.
    Parnes LS; Riddell D
    Laryngoscope; 1993 Jul; 103(7):745-9. PubMed ID: 8341099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intratympanic gentamicin in Menière's disease].
    Huang W; Xu H; Gao B
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 18(1):14-6. PubMed ID: 15088342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The intratympanic treatment of Menière's disease with ototoxic antibiotics. A follow-up study of 55 cases (author's transl)].
    Lange G
    Laryngol Rhinol Otol (Stuttg); 1977 May; 56(5):409-14. PubMed ID: 141554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
    Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K
    Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic gentamicin for Ménière's disease or syndrome.
    Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008234. PubMed ID: 21412917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM; Hehar SS; Bance ML; Rutka JA
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of small dose of intratympanic gentamicin injection on intractable Meniere's disease].
    Dai C; Zhang G; Zhang R; Liu J; Chi F; Wang Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Feb; 21(4):151-3. PubMed ID: 17511170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Intratympanic Gentamicin in Menière's Disease With and Without Migraine.
    Liu YF; Renk E; Rauch SD; Xu HX
    Otol Neurotol; 2017 Aug; 38(7):1005-1009. PubMed ID: 28538472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE; Kamerer DB
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.